ANADYS PHARMACEUTICALS INC

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$35.8M

332 transactions

Summary

ANADYS PHARMACEUTICALS INC is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $10.0MSales: $25.4M30 insiders

Date	Insider	Type	Value
2011-10-20	Joint reporting: QVT Fund LP; QVT Associates GP LLC	Sell	$19.3M
2011-10-17	Joint reporting: QVT Fund LP; QVT Associates GP LLC	Sell	$2.4M
2011-10-21	Joint reporting: QVT Fund LP; QVT Associates GP LLC	Sell	$1.3M
2010-12-29	Joint reporting: QVT Fund LP; QVT Associates GP LLC	Buy	$387K
2010-12-29	Joint reporting: QVT Fund LP; QVT Associates GP LLC	Buy	$73K
2011-01-03	Joint reporting: QVT Fund LP; QVT Associates GP LLC	Buy	$48K
2010-12-28	Joint reporting: QVT Fund LP; QVT Associates GP LLC	Buy	$16K
2010-12-30	Joint reporting: QVT Fund LP; QVT Associates GP LLC	Buy	$444
2011-08-22	Posner Brian S	A	$0
2011-05-27	FOLETTA MARK G	A	$0
2011-05-27	FOTIADIS MARIOS	A	$0
2011-05-27	Labinger Barry	A	$0
2011-05-27	PAPADOPOULOS STELIOS	A	$0
2011-05-27	XANTHOPOULOS KLEANTHIS G	A	$0
2011-03-11	Labinger Barry	A	$0
2011-01-20	Appleman James R.(SVP, Research & CSO)	A	$0
2011-01-20	Eastwood Kevin L.(SVP, Corporate Development)	A	$0
2011-01-20	Freddo James L(SVP, Drug Development and CMO)	A	$0
2011-01-20	REED ELIZABETH E(SVP, Legal Affairs and GC)	A	$0
2011-01-20	Slover Peter T(VP, Finance and Operations)	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

ANADYS PHARMACEUTICALS INC — Contributions, Lobbying & Contracts | Poliscope